Vaquero-Siguero, Nuria
Georgakopoulos, Nikolaos
Puschhof, Maria C. https://orcid.org/0000-0003-2866-9155
Chiotakakos, Ioannis https://orcid.org/0009-0007-6973-3842
Meier, Jasmin
Fey, Sigrid K.
Diamante, Gabriele
Mastel, Manuel
Guiseris-Martinez, Aitana
Belthier, Guillaume
Schleußner, Nikolai
Volk, Julia
Artmann, Carolin
Lim, Bryce https://orcid.org/0000-0002-5688-3952
Koschny, Ronald
Wehling, Cyrill
Ouyang, Kyanna S. https://orcid.org/0009-0007-1198-1405
Günther, Michael https://orcid.org/0009-0001-5091-5060
Kuss, Solveig https://orcid.org/0000-0002-2363-8475
Hoffmeister, Paula
Mall, Moritz https://orcid.org/0000-0002-1278-2594
Neumann, Jens
Ormanns, Steffen https://orcid.org/0000-0002-0754-9034
Schneider, Martin
Schmidt, Thomas
Puschhof, Jens https://orcid.org/0000-0001-9275-4034
Trumpp, Andreas https://orcid.org/0000-0002-6212-3466
van Rheenen, Jacco https://orcid.org/0000-0001-8175-1647
Saez-Rodriguez, Julio https://orcid.org/0000-0002-8552-8976
Köhler, Bruno C. https://orcid.org/0000-0002-7308-0377
Jackstadt, Rene https://orcid.org/0009-0005-6246-2133
Article History
Received: 23 March 2025
Accepted: 26 May 2026
First Online: 1 July 2026
Ethics
Competing interests: J.S.-R. reports funding from GlaxoSmithKline and Pfizer in the last 3 years and fees/honoraria from Travere Therapeutics, STADAPHARM, Astex Pharmaceuticals, Owkin, Pfizer, Vera Therapeutics, Grünenthal, Tempus and Moderna. The other authors declare no competing interests.